{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:59:28Z","timestamp":1791644368919,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["470029\/20110"],"award-info":[{"award-number":["470029\/20110"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004878","name":"Funda\u00e7\u00e3o de Ensino e Pesquisa de Uberaba","doi-asserted-by":"publisher","award":["CDS-922\/2009"],"award-info":[{"award-number":["CDS-922\/2009"]}],"id":[{"id":"10.13039\/501100004878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CDS-APQ-02135-14"],"award-info":[{"award-number":["CDS-APQ-02135-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PNPD-02604\/094"],"award-info":[{"award-number":["PNPD-02604\/094"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.prp.2017.10.021","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T20:17:42Z","timestamp":1509481062000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Angiogenic and antiangiogenic factors in preeclampsia"],"prefix":"10.1016","volume":"214","author":[{"given":"Fernanda Rodrigues","family":"Helmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria Moed","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Cec\u00edlia Dias Maciel","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Guissoni","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyana Barbosa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lu\u00edza Gon\u00e7alves","family":"dos Reis Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Penna","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene Ant\u00f4nia","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Margarida","family":"Etchebehere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Reis","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Rosa Miranda","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.10.021_bib0005","doi-asserted-by":"crossref","first-page":"586578","DOI":"10.1155\/2012\/586578","article-title":"Preeclampsia 2012","volume":"2012","author":"Eiland","year":"2012","journal-title":"J. Pregnancy"},{"key":"10.1016\/j.prp.2017.10.021_bib0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.prp.2017.10.021_bib0015","series-title":"Hypertension in Pregnancy","author":"ACOG","year":"2013"},{"key":"10.1016\/j.prp.2017.10.021_bib0020","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0021-9258(18)69351-2","article-title":"Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands","volume":"235","author":"Lerner","year":"1960","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2017.10.021_bib0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.preghy.2012.06.003","article-title":"Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia","volume":"2","author":"Liu","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0030","first-page":"8","article-title":"The history of preeclampsia and eclampsia as seen by a nephrologist","volume":"31","author":"Lindheimer","year":"2013","journal-title":"Clin. Rev."},{"key":"10.1016\/j.prp.2017.10.021_bib0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ogc.2010.02.013","article-title":"Abnormal placentation angiogenic factors, and the pathogenesis of preeclampsia","volume":"37","author":"Silasi","year":"2010","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.prp.2017.10.021_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","article-title":"Inflammation and pre-eclampsia","volume":"11","author":"Borzychowski","year":"2006","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10641950701885170","article-title":"Detection of circulating trophoblast particles in peripheral maternal blood in preeclampsia complicated pregnancies","volume":"27","author":"Schmidt","year":"2008","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.prp.2017.10.021_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10995-006-0147-2","article-title":"Impact of prenatal care on infant survival in Bangladesh","volume":"11","author":"Hong","year":"2007","journal-title":"Matern. Child Health J."},{"key":"10.1016\/j.prp.2017.10.021_bib0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1552-6909.2010.01144.x","article-title":"Identifying health disparities and social inequities affecting childbearing women and infants","volume":"39","author":"Walker","year":"2010","journal-title":"J. Obstet. Gynecol. Neonatal Nurs."},{"key":"10.1016\/j.prp.2017.10.021_bib0060","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2017.10.021_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2015.05.004","article-title":"Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia","volume":"447","author":"Jardim","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2017.10.021_bib0070","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1096\/fj.06-6616com","article-title":"Interferon-gamma inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels","volume":"20","author":"Lash","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2017.10.021_bib0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.prp.2017.10.021_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semnephrol.2010.10.004","article-title":"Angiogenic factors and preeclampsia","volume":"31","author":"Maynard","year":"2011","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.prp.2017.10.021_bib0090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1210\/en.2010-1088","article-title":"Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response","volume":"152","author":"Nogueira","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2017.10.021_bib0095","series-title":"Mortalidade e nascidos vivos: \u00f3bitos maternos","author":"Brasil","year":"2015"},{"key":"10.1016\/j.prp.2017.10.021_bib0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","article-title":"Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy","volume":"4","author":"Pijnenborg","year":"1983","journal-title":"Placenta"},{"key":"10.1016\/j.prp.2017.10.021_bib0105","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.ogx.0000193879.79268.59","article-title":"The role of placental oxidative stress and lipid peroxidation in preeclampsia","volume":"60","author":"Gupta","year":"2005","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.prp.2017.10.021_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/157340710790711737","article-title":"Circulating and vascular bioactive factors during hypertension in pregnancy","volume":"6","author":"Tanbe","year":"2010","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.prp.2017.10.021_bib0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0009-9120(03)00060-2","article-title":"Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines","volume":"36","author":"Kharfi","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.prp.2017.10.021_bib0120","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2017.10.021_bib0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10456-012-9261-5","article-title":"The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia","volume":"15","author":"Ramma","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.prp.2017.10.021_bib0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s004040000104","article-title":"The renin-aldosterone system during normal and hypertensive pregnancy","volume":"264","author":"Elsheikh","year":"2001","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.prp.2017.10.021_bib0135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.HYP.0000186328.90667.95","article-title":"Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops","volume":"46","author":"Khan","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2017.10.021_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MNH.0000000000000105","article-title":"Pathogenesis of preeclampsia","volume":"24","author":"Sircar","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/apha.12106","article-title":"Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology","volume":"208","author":"Palei","year":"2013","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.prp.2017.10.021_bib0150","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.prp.2017.10.021_bib0155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-0528.2006.00882.x","article-title":"Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction","volume":"113","author":"Egbor","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.prp.2017.10.021_bib0165","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1242\/dev.066589","article-title":"A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia","volume":"138","author":"Hunkapiller","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.prp.2017.10.021_bib0170","doi-asserted-by":"crossref","first-page":"e3905","DOI":"10.1371\/journal.pone.0003905","article-title":"STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas","volume":"3","author":"Rigourd","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2017.10.021_bib0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preghy.2010.12.002","article-title":"Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia","volume":"1","author":"Burton","year":"2011","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jri.2015.07.004","article-title":"Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia","volume":"114","author":"Charnock-Jones","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.prp.2017.10.021_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/jhh.2016.17","article-title":"eNOS\/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia","volume":"31","author":"Du","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tjog.2014.11.002","article-title":"Expression of markers of endoplasmic reticulum stress-induced apoptosis in the placenta of women with early and late onset severe pre-eclampsia","volume":"54","author":"Fu","year":"2015","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0195","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/humrep\/dep216","article-title":"Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages","volume":"24","author":"Moffett","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2017.10.021_bib0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jri.2016.09.002","article-title":"The role of decidual NK cells in pregnancies with impaired vascular remodelling","volume":"119","author":"Cartwright","year":"2017","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.prp.2017.10.021_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1189\/jlb.2A0614-282R","article-title":"Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia","volume":"97","author":"Wallace","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.prp.2017.10.021_bib0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jri.2015.04.003","article-title":"Decidual natural killer cells regulate vessel stability: implications for impaired spiral artery remodelling","volume":"110","author":"Fraser","year":"2015","journal-title":"J. Reprod. Immunol."},{"issue":"Suppl. A","key":"10.1016\/j.prp.2017.10.021_bib0215","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.placenta.2006.11.008","article-title":"How Does the maternal immune system contribute to the development of pre-eclampsia?","volume":"28","author":"Moffett","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.prp.2017.10.021_bib0220","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-1016256","article-title":"Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia","volume":"16","author":"Walsh","year":"1998","journal-title":"Semin. Reprod. Endocrinol."},{"key":"10.1016\/j.prp.2017.10.021_bib0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1028-4559(09)60224-2","article-title":"Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia","volume":"45","author":"Hung","year":"2006","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/hr.2010.31","article-title":"Circulating angiogenic factors and their association with birth outcomes in preeclampsia","volume":"33","author":"Kulkarni","year":"2010","journal-title":"Hypertens. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.prp.2017.10.021_bib0240","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S0049-3848(11)70020-2","article-title":"New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications","volume":"127","author":"Ahmed","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0245","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006585","article-title":"Angiogenic factors in preeclampsia and related disorders","volume":"2","author":"Cerdeira","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0250","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/humrep\/deu017","article-title":"Increased angiogenic factor secretion by decidual natural killer cells from pregnancies with high uterine artery resistance alters trophoblast function","volume":"29","author":"Wallace","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2017.10.021_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-014-9452-3","article-title":"Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia","volume":"18","author":"Pratt","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.prp.2017.10.021_bib0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0265","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0270","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2017.10.021_bib0275","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Shibuya","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0280","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mvr.2007.03.004","article-title":"Roles for VEGF in the adult","volume":"74","author":"Maharaj","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.preghy.2012.01.005","article-title":"Second trimester anti-angiogenic proteins and preeclampsia","volume":"2","author":"Haggerty","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0290","doi-asserted-by":"crossref","first-page":"e97632","DOI":"10.1371\/journal.pone.0097632","article-title":"Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia","volume":"9","author":"Perucci","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2017.10.021_bib0295","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0300","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajpath.2011.11.014","article-title":"MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin","volume":"180","author":"Kaitu\u2019u-Lino","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2017.10.021_bib0305","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0310","first-page":"888","article-title":"The relationship between circulating endothelin-1: soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia","volume":"180","author":"Aggarwal","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2017.10.021_bib0315","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.arcmed.2014.10.004","article-title":"Preeclampsia is associated with lower production of vascular endothelial growth factor by peripheral blood mononuclear cells","volume":"45","author":"Cardenas-Mondragon","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0325","first-page":"147","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"Wang","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.prp.2017.10.021_bib0330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5830\/CVJA-2012-003","article-title":"The role of angiogenic: anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia","volume":"23","author":"Govender","year":"2012","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.prp.2017.10.021_bib0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000368605","article-title":"Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy","volume":"37","author":"Llurba","year":"2015","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.prp.2017.10.021_bib0345","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","article-title":"Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia","volume":"46","author":"Lam","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2017.10.021_bib0350","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/CIRCULATIONAHA.112.101261","article-title":"Oxysterol-induced soluble endoglin release and its involvement in hypertension","volume":"126","author":"Valbuena-Diez","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2017.10.021_bib0355","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MNH.0b013e328365ad98","article-title":"Angiogenic factors in preeclampsia: potential for diagnosis and treatment","volume":"22","author":"Goel","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0360","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0365","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2017.10.021_bib0370","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2393-13-85","article-title":"First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia","volume":"13","author":"Saxena","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.prp.2017.10.021_bib0380","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajog.2007.06.079","article-title":"Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors","volume":"198","author":"Purwosunu","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1447-0756.2011.01773.x","article-title":"Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia","volume":"38","author":"Kim","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0390","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1471-0528.2003.02162.x","article-title":"Glomerular endotheliosis in normal pregnancy and pre-eclampsia","volume":"110","author":"Strevens","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.prp.2017.10.021_bib0395","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"Vaisbuch","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0400","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0405","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2017.10.021_bib0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1095\/biolreprod.112.099861","article-title":"The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms","volume":"87","author":"Laresgoiti-Servitje","year":"2012","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.prp.2017.10.021_bib0415","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ajh.2010.70","article-title":"The effect of immune factors tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy","volume":"23","author":"Parrish","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.prp.2017.10.021_bib0420","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","article-title":"Preeclampsia is associated with reduced serum levels of placenta growth factor","volume":"179","author":"Torry","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0425","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1677\/JOE-10-0027","article-title":"Role of extracellular signal-regulated kinase and AKT cascades in regulating hypoxia-induced angiogenic factors produced by a trophoblast-derived cell line","volume":"206","author":"Fujita","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.prp.2017.10.021_bib0430","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvq346","article-title":"Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling","volume":"89","author":"Cindrova-Davies","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"Suppl","key":"10.1016\/j.prp.2017.10.021_bib0435","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.placenta.2011.11.021","article-title":"Review: biochemical markers to predict preeclampsia","volume":"33","author":"Anderson","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.prp.2017.10.021_bib0440","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpm-2012-0248","article-title":"The course of angiogenic factors in early- vs late-onset preeclampsia and HELLP syndrome","volume":"41","author":"Schaarschmidt","year":"2013","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0445","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajog.2007.05.022","article-title":"Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia","volume":"197","author":"Unal","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0450","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0455","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00404-011-1960-4","article-title":"Serum PLGF as a potential biomarker for predicting the onset of preeclampsia","volume":"285","author":"Ghosh","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.prp.2017.10.021_bib0460","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2017.10.021_bib0465","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/hr.2010.92","article-title":"Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia","volume":"33","author":"Molvarec","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.prp.2017.10.021_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2393-14-292","article-title":"Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis","volume":"14","author":"Stubert","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.prp.2017.10.021_bib0475","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.00754","article-title":"Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia","volume":"61","author":"Lea\u00f1os-Miranda","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2017.10.021_bib0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0485","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.prp.2017.10.021_bib0490","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1600-0412.2012.01516.x","article-title":"Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction","volume":"91","author":"Vatten","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2017.10.021_bib0495","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13 PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.prp.2017.10.021_bib0500","doi-asserted-by":"crossref","first-page":"e4453","DOI":"10.1371\/journal.pone.0004453","article-title":"Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia","volume":"4","author":"Reddy","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2017.10.021_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-015-1186-9","article-title":"Correlation between cell-free mRNA expressions and PLGF protein level in severe preeclampsia","volume":"8","author":"Pramatirta","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.prp.2017.10.021_bib0510","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.3895","article-title":"Variants in the fetal genome near FLT1 are associated with risk of preeclampsia","volume":"49","author":"McGinnis","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2017.10.021_bib0515","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.10.021_bib0520","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.prp.2017.10.021_bib0525","first-page":"7","article-title":"Risk factors and effective management of preeclampsia","volume":"8","author":"English","year":"2015","journal-title":"Integr. Blood Press Control"},{"key":"10.1016\/j.prp.2017.10.021_bib0530","first-page":"CD001805","article-title":"Plasma volume expansion for treatment of women with pre-eclampsia","author":"Duley","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.prp.2017.10.021_bib0535","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2017.10.021_bib0540","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/HYPERTENSIONAHA.114.04850","article-title":"Cardiovascular disease risk factors after early-onset preeclampsia late-onset preeclampsia, and pregnancy-induced hypertension","volume":"65","author":"Veerbeek","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2017.10.021_bib0545","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/1471-0528.13057","article-title":"Cardiovascular disease risk is only elevated in hypertensive formerly preeclamptic women","volume":"122","author":"Breetveld","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.prp.2017.10.021_bib0550","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004158","article-title":"Incident coronary heart disease after preeclampsia: role of reduced fetal growth, preterm delivery, and parity","volume":"6","author":"Riise","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.prp.2017.10.021_bib0555","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817302339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817302339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T21:19:55Z","timestamp":1656451195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817302339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0344033817302339"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.10.021","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenic and antiangiogenic factors in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}